Life style change and reverse cholesterol transport in obese women

Physiological Research

Volumn 58, Issue SUPPL.1, 2009, Pages

  Lesná, I Králová ^a   Suchanek P ^a   Kovar J ^a   Poledne, R ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cholesterol efflux; Life style modification; Lipoprotein metabolism; Reverse cholesterol transport

Indexed keywords

APOA1 PROTEIN, HUMAN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COUNSELING; DIET; EXERCISE; FEMALE; HUMAN; MACROPHAGE; METABOLISM; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOPHYSIOLOGY; RISK REDUCTION; TIME; TRANSPORT AT THE CELLULAR LEVEL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; COMBINED MODALITY THERAPY; COUNSELING; DIET; EXERCISE; FEMALE; HUMANS; MACROPHAGES; OBESITY; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 72649100001     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Berroughi H, Maxim I, Cloutier M, Grenier G, Khalil A: Age-related impairment of HDL-mediated cholesterol efflux. J Lipid Res 48: 328-336, 2007.
2. Boadu E, Bilbey NJ, Francis A Cellular cholesterol substrate pools for adenosine-triphosphate cassette transporter A1+dependent high-density lipoprotein formation. Curr Opin Lipidol 19: 270-276, 2008.
3. Catalano G, Duchene E, Julia Z, Le Goff W, Bruckert E, Chapman MJ, Guerin M : Cellular SR-BI and ABCAl-mediated cholesterol efflux are gender-specific in healthy subjects. J Lipid Res 49: 635-643, 2008.
4. Cífková R, Bruthans J, Adámková V, Jozífová M, Galovcová M, Wohlfahrt P, Krajčoviechová A, Lánská V Longitudinal trends in major cardiovascular risk factors in the Czech population in1985 to 2007/8. Czech MONICA and Czech post-MONICA Study. Eur J Cardiol Prevent Rehabilit 16: S6, 2009.
5. De Vries R, Kerstens MN, Sluiter WJ, Groen AK, Van Tol A, Dullaart RPF : Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment. Diabetologia 48: 1105-1113, 2005.
6. Dvořáková-Lorenzová A, Suchánek P, Havel PJ, Stávek P, Karasová L, Valenta Z, Tintěra J, Poledne R : The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55: 359-365, 2006.
7. Hoang A, Tefft CH, Duffy SJ, Formosa M, Henstridge DC, Kingwell BA, Sviridov D : ABCA1 expression in humans is associated with physical activity and alcohol consumption. Atherosclerosis 197: 197-203, 2008.
8. Houmard JA, Bruno NJ, Bruner RK, Mccammon MR, Israel RG, Barakat HA : Effects of exercise training on the chemical composition of plasma LDL. Arterioscler Thromb 14: 325-330, 1994.
9. Kelley GA, Kelley K, Tran ZV Aerobic exercise and lipids and lipoproteins in women: a meta-analysis randomized control trials. J Women Healths 13: 1148-1164, 2004.
10. Marcel YL, Ouimet M, Wang MD Regulation of cholesterol efflux from macrophages. Curr Opin Lipidol 19: 455-461, 2008.
11. Mauldin JP, Nagelin MH, Wojcik AJ, Srinivasan S, Skaflen MD, Ayers CR, McNamara CA, Hedrick CC Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation May 27: 2785-2792, 2008.
12. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, Mccormick SP, Remaley AT, Sviridov D, Chin-Dusting J High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28: 2071-2077, 2008.
13. Palmer AM, Murphy N, Graham A Triglyceride rich lipoproteins inhibit cholesterol efflux to (apo) apoliprotein A1 from human macrophage foam cells. Atherosclerosis 173:27-38, 2004.
14. Poledne R, Stávek P, Pitha J, Baumgartner M, Omáčka A: Effect of exercise on LDL particle size. Cor Vasa 40: 217-221, 1998.
15. Poledne R, Králová Lesná I Direct method of reverse cholesterol transport measurement. Klin Biochem Metab 17: 96-99, 2009.
16. Ross R: The pathogenesis of atherosclerosis: an update. N Engl J Med 314: 488-500, 1986.
17. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P, Assmann G Tangier disease is caused by mutation in the gene according ATP-binding cassette transporter 1. Nat Genet 12: 352-355, 1999.
18. Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, Watanabe H, Rantala E, Soderlund S, Hiukka A, Kovanen PT, Jauhiainen M, Peltonen L, Taskinen MR Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL. J Lipid Res 48: 1409-1416, 2007.
19. Suchánek P, Lorenzová A, Poledne R, Hubáček JA Changes of plasma lipids during weight reduction in females depends on APOA5 variants. Ann Nutr Metab 53: 104-108, 2008.
20. Sviridov D, Nestel P: Dynamics of reverse cholesterol transport; protection against atherosclerosis. Atherosclerosis 161: 245-254, 2002.
21. Vogt L, Laverman GD, Van OL A, Groen AK, Navis G, Dullaart RP Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrol Dial Transplant 21: 101-106, 2006.
22. Von Eckardstein A, Nofer JR, Assmann G High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21: 13-27, 2001.
23. Wang X, Liao D, Bharadwaj U, Li M, Yao Q, Chen CH C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 28: 519-526, 2008.
24. Williams PT, Krauss RM, Vranizan KM, Wood PDS Changes in lipoprotein subfractions during dietinduced and exercise-induced weight loss in moderately overweight men. Circulation 81: 1293-1304, 1990.
25. Wilson PR, Abbott RD, Castelli WP: High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8: 737-741, 1988.